Pembrolizumab and Lenvatinib Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 2

Top Sponsors

University College, London1
Peking Union Medical College Hospital1

Indications

Cancer2
Liver Disease1
Biliary Tract Neoplasms Immunotherapy1
Liver Cancer1
Hepatocellular Carcinoma1

Other2 trials

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Phase 2

Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.